Laparoscopic pelvic lymphnodes dissection for prostate and bladder cancer: indication, techniques and results.

P. Puppo, M. Perachino, G. Ricciotti, G. Carmignani, M. Maffezzini

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Laparoscopic pelvic lymphadenectomy has been proposed for staging of prostate cancer and it might be used, in selected cases, also in bladder cancer. On a total of 31 laparoscopic lymphadenectomies (LPND), 18 for prostate cancer and 13 for bladder cancer, we found positive nodes in 8 cases (26.1%), 4 in prostate and 4 in bladder cancer group. We had no intraoperative complications and negligible postoperative complications (in 10% of cases shoulder-tip pain and in 24% subcutaneous emphysema); all these spontaneously disappeared after 24-36 hours. Patients with negative nodes underwent radical surgery except two prostate cancer patients who underwent radiotherapy, and patients with positive nodes underwent hormonal therapy (for prostate cancer) or chemoradiotherapy protocol (for bladder cancer). In conclusion, laparoscopic lymphadenectomy proved to be a feasible and safe method for staging urological malignancies, being less invasive, with shorter hospitalization and postoperative convalescence than open lymphadenectomy. It should be mainly indicated in high risk prostate cancer patients (elevated PSA and/or Gleason score). In bladder cancer patients, it could be proposed in bladder sparing investigational protocols, as the percentage of pelvic nodes metastases in T2/T3 bladder cancer is sufficiently high to justify an additional staging procedure.

Original languageEnglish
Pages (from-to)117-123
Number of pages7
JournalArchivio Italiano di Urologia e Andrologia
Volume66
Issue number3
Publication statusPublished - Jun 1994

Fingerprint

Urinary Bladder Neoplasms
Dissection
Prostatic Neoplasms
Lymph Node Excision
Subcutaneous Emphysema
Shoulder Pain
Neoplasm Grading
Intraoperative Complications
Chemoradiotherapy
Prostate
Urinary Bladder
Hospitalization
Radiotherapy
Neoplasm Metastasis
Neoplasms

ASJC Scopus subject areas

  • Nephrology
  • Urology

Cite this

Laparoscopic pelvic lymphnodes dissection for prostate and bladder cancer : indication, techniques and results. / Puppo, P.; Perachino, M.; Ricciotti, G.; Carmignani, G.; Maffezzini, M.

In: Archivio Italiano di Urologia e Andrologia, Vol. 66, No. 3, 06.1994, p. 117-123.

Research output: Contribution to journalArticle

Puppo, P, Perachino, M, Ricciotti, G, Carmignani, G & Maffezzini, M 1994, 'Laparoscopic pelvic lymphnodes dissection for prostate and bladder cancer: indication, techniques and results.', Archivio Italiano di Urologia e Andrologia, vol. 66, no. 3, pp. 117-123.
Puppo, P. ; Perachino, M. ; Ricciotti, G. ; Carmignani, G. ; Maffezzini, M. / Laparoscopic pelvic lymphnodes dissection for prostate and bladder cancer : indication, techniques and results. In: Archivio Italiano di Urologia e Andrologia. 1994 ; Vol. 66, No. 3. pp. 117-123.
@article{e706d4f68de64d97b38b27b30a2d177c,
title = "Laparoscopic pelvic lymphnodes dissection for prostate and bladder cancer: indication, techniques and results.",
abstract = "Laparoscopic pelvic lymphadenectomy has been proposed for staging of prostate cancer and it might be used, in selected cases, also in bladder cancer. On a total of 31 laparoscopic lymphadenectomies (LPND), 18 for prostate cancer and 13 for bladder cancer, we found positive nodes in 8 cases (26.1{\%}), 4 in prostate and 4 in bladder cancer group. We had no intraoperative complications and negligible postoperative complications (in 10{\%} of cases shoulder-tip pain and in 24{\%} subcutaneous emphysema); all these spontaneously disappeared after 24-36 hours. Patients with negative nodes underwent radical surgery except two prostate cancer patients who underwent radiotherapy, and patients with positive nodes underwent hormonal therapy (for prostate cancer) or chemoradiotherapy protocol (for bladder cancer). In conclusion, laparoscopic lymphadenectomy proved to be a feasible and safe method for staging urological malignancies, being less invasive, with shorter hospitalization and postoperative convalescence than open lymphadenectomy. It should be mainly indicated in high risk prostate cancer patients (elevated PSA and/or Gleason score). In bladder cancer patients, it could be proposed in bladder sparing investigational protocols, as the percentage of pelvic nodes metastases in T2/T3 bladder cancer is sufficiently high to justify an additional staging procedure.",
author = "P. Puppo and M. Perachino and G. Ricciotti and G. Carmignani and M. Maffezzini",
year = "1994",
month = "6",
language = "English",
volume = "66",
pages = "117--123",
journal = "Archivio Italiano di Urologia Nefrologia Andrologia",
issn = "1120-8538",
publisher = "Edizioni Scripta Manent s.n.c.",
number = "3",

}

TY - JOUR

T1 - Laparoscopic pelvic lymphnodes dissection for prostate and bladder cancer

T2 - indication, techniques and results.

AU - Puppo, P.

AU - Perachino, M.

AU - Ricciotti, G.

AU - Carmignani, G.

AU - Maffezzini, M.

PY - 1994/6

Y1 - 1994/6

N2 - Laparoscopic pelvic lymphadenectomy has been proposed for staging of prostate cancer and it might be used, in selected cases, also in bladder cancer. On a total of 31 laparoscopic lymphadenectomies (LPND), 18 for prostate cancer and 13 for bladder cancer, we found positive nodes in 8 cases (26.1%), 4 in prostate and 4 in bladder cancer group. We had no intraoperative complications and negligible postoperative complications (in 10% of cases shoulder-tip pain and in 24% subcutaneous emphysema); all these spontaneously disappeared after 24-36 hours. Patients with negative nodes underwent radical surgery except two prostate cancer patients who underwent radiotherapy, and patients with positive nodes underwent hormonal therapy (for prostate cancer) or chemoradiotherapy protocol (for bladder cancer). In conclusion, laparoscopic lymphadenectomy proved to be a feasible and safe method for staging urological malignancies, being less invasive, with shorter hospitalization and postoperative convalescence than open lymphadenectomy. It should be mainly indicated in high risk prostate cancer patients (elevated PSA and/or Gleason score). In bladder cancer patients, it could be proposed in bladder sparing investigational protocols, as the percentage of pelvic nodes metastases in T2/T3 bladder cancer is sufficiently high to justify an additional staging procedure.

AB - Laparoscopic pelvic lymphadenectomy has been proposed for staging of prostate cancer and it might be used, in selected cases, also in bladder cancer. On a total of 31 laparoscopic lymphadenectomies (LPND), 18 for prostate cancer and 13 for bladder cancer, we found positive nodes in 8 cases (26.1%), 4 in prostate and 4 in bladder cancer group. We had no intraoperative complications and negligible postoperative complications (in 10% of cases shoulder-tip pain and in 24% subcutaneous emphysema); all these spontaneously disappeared after 24-36 hours. Patients with negative nodes underwent radical surgery except two prostate cancer patients who underwent radiotherapy, and patients with positive nodes underwent hormonal therapy (for prostate cancer) or chemoradiotherapy protocol (for bladder cancer). In conclusion, laparoscopic lymphadenectomy proved to be a feasible and safe method for staging urological malignancies, being less invasive, with shorter hospitalization and postoperative convalescence than open lymphadenectomy. It should be mainly indicated in high risk prostate cancer patients (elevated PSA and/or Gleason score). In bladder cancer patients, it could be proposed in bladder sparing investigational protocols, as the percentage of pelvic nodes metastases in T2/T3 bladder cancer is sufficiently high to justify an additional staging procedure.

UR - http://www.scopus.com/inward/record.url?scp=0028454187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028454187&partnerID=8YFLogxK

M3 - Article

C2 - 7920741

AN - SCOPUS:0028454187

VL - 66

SP - 117

EP - 123

JO - Archivio Italiano di Urologia Nefrologia Andrologia

JF - Archivio Italiano di Urologia Nefrologia Andrologia

SN - 1120-8538

IS - 3

ER -